Medications for secondary CVD prevention underused worldwide
Regardless of country-level income classification, medications for the secondary prevention of CVD remains underutilized and patients likely remain undertreated, researcher reported.Data form the Prospective Urban Rural Epidemiology (PURE) study were published in the Journal of the American College of Cardiology.